A Global In-Vitro Diagnostics Company Based in Northern Ireland

Founded in August 2013 by Professor Brian Walker and Dr Lorraine Martin, ProAxsis promotes a range of assay kits designed for the specific measurement of active protease biomarkers of disease. 

Our easy-to-use tests incorporate patented technology called “ProteaseTags^®”; smart molecules which trap an active protease within a complex biological sample and enable a visual readout of its presence.

The company has developed activity-based immunoassays targeting Neutrophil Elastase (NE) and Proteinase 3, biomarkers of lung infection and inflammation in chronic respiratory diseases such as COPD, Bronchiectasis, and Cystic Fibrosis.